Recent Quotes
My Watchlist
Indicators
Local Stocks
Local Stocks
Energy Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Biogen, Inc. (NQ: BIIB )

272.88 USD -4.38 (-1.58%)
Official Closing Price Updated: 7:58 PM EST, Feb 26, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Biogen, Inc.

< Previous 1 2
...
93 94 95 96 97 98 99 100 Next >
Biogen Says EU Medicines Agency Accepted Its Investigational Alzheimer's Disease Treatment Aducanumab
Biogen Inc. (NASDAQ: BIIB) revealed that aducanumab, its investigational treatment for early Alzheimer's disease (AD), was ... 
Tags FDA News General
From Benzinga
BRIEF-Biogen's Alzheimer drug Aducanumab Accepted into EMA's PRIME Program
* Biogen's Investigational Alzheimer's Disease Treatment Aducanumab Accepted Into European Medicines Agency's Prime Program 
Tags companyNews
From Reuters: Company News
Biogen Inc: Run With the Bulls for Triple-Digit Profits (BIIB)
 
Tags Trading Advice NASDAQ:BIIB
From InvestorPlace
10 Biotech Stocks With Symptoms of Strong Growth
 
Tags NYSE:MRK NASDAQ:ALXN NASDAQ:BIIB
From InvestorPlace
Nasdaq 100 Movers: CHTR, BIIB
In early trading on Tuesday, shares of Biogen (BIIB) topped the list of the day's best performing components of the Nasdaq 100 index, trading up 2.7%. Year to date, Biogen has lost about 5.2% of its... 
Tags Stocks
From Market News Video
Biogen Gets Favorable View For TYSABRI Use In Highly Active RRMS
Biogen Inc (NASDAQ: BIIB) revealed Tuesday that the Committee of Medicinal Products for Human Use (CHMP) of the European Medicines ... 
Tags News FDA General
From Benzinga
UPDATE 1-Biogen, AbbVie once-monthly MS injection wins U.S. approval
May 27 (Reuters) - The U.S. Food and Drug Administration on Friday approved a once-monthly injection for multiple sclerosis from Biogen Inc and AbbVie Inc, with a boxed warning. 
Tags companyNews
From Reuters: Company News
Biogen, AbbVie once-monthly MS injection wins U.S. FDA approval
May 27 (Reuters) - The U.S. Food and Drug Administration on Friday approved a once-monthly injection for multiple sclerosis from Biogen Inc and AbbVie Inc. 
Tags companyNews
From Reuters: Company News
BRIEF-U.S. FDA approves Zinbryta to treat multiple sclerosis
* Zinbryta has a boxed warning & is available only through a restricted distribution program under a risk evaluation and mitigation strategy 
Tags companyNews
From Reuters: Company News
Notable Friday Option Activity: BIIB, SEMG, LGF
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Biogen Inc (BIIB), where a total of 6,441 contracts have traded so far, representing... 
Tags Stocks
From Market News Video
Government Study: Cellphone Radiation Linked To Cancer
Radio frequencies frequently emitted by cellphones can cause cancer, according to partial findings of a government study on rats, ... 
Tags Ron Melnick IYH News
From Benzinga
Bullish Two Hundred Day Moving Average Cross - BIIB
In trading on Thursday, shares of Biogen Inc (BIIB) crossed above their 200 day moving average of $280.19, changing hands as high as $284.28 per share. Biogen Inc shares are currently trading up about... 
Tags Stocks
From Market News Video
Healthcare Sector Is Looking A Tad Better: M&A Boosts Biotech…Update
A broad rally today surprised many traders. Technology was a leader up 2% followed by healthcare up 1.49%. US new single family home sales hit an 8 year high a sign of growing prospects for the... 
Tags Stocks / Equities ETF's Healthcare
From Blogs - TalkMarkets
Noteworthy Thursday Option Activity: AHP, WDAY, BIIB
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Ashford Hospitality Prime Inc (AHP), where a total volume of 1,023 contracts has... 
Tags Stocks
From Market News Video
Noteworthy ETF Outflows: IVW, MO, PCLN, BIIB
Symbols mentioned in this story: IVW, MO, PCLN, BIIB Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''... 
Tags ETFs
From ETF Channel
Four reasons for investors to buy biotechnology stocks now
A big driver is mergers and acquisitions, says Michael Brush. 
Tags MDVN LLY SNY
From MarketWatch
Has A Biotech Recovery Started Yet?
After a brutal winter, is a warm summer coming for biotech? Citi’s Robyn Karnauskas and Vice President Mohit Bansal asked in a ... 
Tags CELG BIIB AMGN
From Benzinga
Biogen Inc (BIIB) Spinout: A Graceful Exit for the Hemophilia Biz
 
Tags NYSE:BXLT Market Insight, Financial Articles NASDAQ:BIIB
From InvestorPlace
BRIEF-Regenxbio and Biogen enter agreement for development of gene therapy treatments
* Regenxbio and Biogen enter exclusive license agreement for the development of gene therapy treatments for rare genetic vision disorders 
Tags companyNews
From Reuters: Company News
Alphabet Inc: Google Diversifies Into Health With ‘Smart Lenses’ Patent
 
Tags NYSE:JNJ NYSE:ABBV NASDAQ:GOOGL
From InvestorPlace
BRIEF-Sobi says Alprolix wins regulatory approval in EU
* Says Alprolix (rfixfc) approved in the EU for the treatment of Haemophilia B 
Tags companyNews
From Reuters: Company News
Notable ETF Outflow Detected - IWB, LLY, TWX, BIIB
Symbols mentioned in this story: IWB, LLY, TWX, BIIB Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''... 
Tags ETFs
From ETF Channel
Analysts Forecast 12% Upside For The Holdings of OEF
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Large Cap Biopharmaceuticals Q1 2016 Metrics: Earnings Show Limited Growth Prospects
Two of our four top stocks large cap picks Abbvie and Bristol-Myers Squibb are up since we recommended them because of their growth potential in “Immuno-Oncology”. 
Tags Healthcare Stocks / Equities
From Blogs - TalkMarkets
Biogen Inc (BIIB) to Spin Off Hemophilia Drug Business
 
Tags NASDAQ:BIIB
From InvestorPlace
The Next Sector Rotation Will Be To Biotechs
A sector rotation is common, particularly in times of market volatility. However, picking the timing and the right sector is always a ... 
Tags Benzinga PreMarket Prep GILD Biotech Stocks
From Benzinga
Biogen Plans To Spin-Off Its Hemophilia Unit As Publicly Traded Firm
Biogen Inc. (NASDAQ: BIIB) revealed its intension to spin off its hemophilia business as an independent, publicly traded firm. ... 
Tags Asset Sales General Benzinga
From Benzinga
BRIEF-Biogen announces intent to spin off its hemophilia business
* Biogen announces intent to spin off its hemophilia business 
Tags companyNews
From Reuters: Company News
Early movers: PFE, BIIB, TAP, CVS, MNK, IMS, CLX, COST & more
These are the stocks posting the largest moves before the bell. 
Tags Investing/Investment Strategy Apple Inc Wal Mart Stores Inc
From CNBC.com News
Biogen to spin off hemophilia drug business into a public company
May 3 (Reuters) - Drugmaker Biogen Inc said on Tuesday it intends to spin off its hemophilia drug business as an independent, publicly traded company in a tax-free transaction. 
Tags companyNews
From Reuters: Company News
< Previous 1 2
...
93 94 95 96 97 98 99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.